Bridges Investment Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.08M Sell
21,558
-17,079
-44% -$2.53M 0.05% 129
2026
Q1
$3.6M Buy
38,637
+10,237
+36% +$907K 0.05% 128
2025
Q4
$2.28M Sell
28,400
-3,299
-10% -$276K 0.03% 159
2025
Q3
$3.1M Buy
31,699
+1,924
+6% +$155K 0.04% 136
2025
Q2
$2.08M Buy
29,775
+3,982
+15% +$227K 0.03% 173
2025
Q1
$1.28M Buy
25,793
+14,589
+130% +$922K 0.02% 214
2024
Q4
$783K Buy
11,204
+6,084
+119% +$505K 0.01% 238
2024
Q3
$537K Hold
5,120
0.01% 273
2024
Q2
$728K Buy
+5,120
New +$590K 0.01% 227

Other funds holding ACLS

Bridges Investment Management's ACLS Position: Q2 2026 in Review

Bridges Investment Management reduced its Axcelis (ACLS) stake by 44% in Q2 2026, selling an estimated $2.53M and leaving 21,558 shares worth $4.08M. The position accounts for 0.05% of the portfolio, ranked #129.

Bridges Investment Management first reported a position in ACLS in Q2 2024 and has held it in 9 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Bridges Investment Management held 21,558 shares of Axcelis worth $4.08M as of Q2 2026.
  • Bridges Investment Management sold 17,079 Axcelis shares in Q2 2026, an estimated $2.53M.
  • Axcelis made up 0.05% of Bridges Investment Management's portfolio in Q2 2026, its #129 holding.
  • Bridges Investment Management first reported a position in Axcelis in Q2 2024 and has held it in 9 quarters since.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.